PodParley PodParley
Unresearched GLP-1 Agonist Practices

EPISODE · Jul 10, 2024 · 8 MIN

Unresearched GLP-1 Agonist Practices

from Weight and Healthcare · host Ragen Chastain

As I discuss the issues of GLP-1 agonist and GLP-1/GIP co-agonist weight loss drugs Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound)I’ve been increasingly hearing from people who are engaged in practices with these drugs that are not remotely evidence based. Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe

NOW PLAYING

Unresearched GLP-1 Agonist Practices

0:00 8:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

URL copied to clipboard!